T-Therapeutics
Cambridge
About T-Therapeutics
T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $91.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2025)
- Website: t-therapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/t-therapeutics-69026 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.